A Non-interventional Post Authorisation Safety Study (PASS) of Patients with MoCD Type A Treated with NULIBRY (fosdenopterin) First published 17/05/2024 Last updated 03/07/2025 EU PAS number:EUPAS1000000093 Study Planned